{
    "code": "02023934",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023934",
    "time": "2019-08-09 03:03:48",
    "許可證字號": "衛署藥輸字第023934號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/03\/02",
    "發證日期": "93\/03\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202393408",
    "中文品名": "加力體能注射劑1公克",
    "英文品名": "CARNITENE INJECTIONS 1G",
    "適應症": "預防及治療末期腎病因血液透析引起的CARNITINE缺乏症。",
    "劑型": "",
    "包裝": "5公撮\/安瓿 ，100支安瓿以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "L-CARNITINE INNER SALT",
    "主製造廠": {
        "申請商名稱": "1605101100  翰亨實業股份有限公司",
        "申請商地址": "臺北市中山區民生東路二段174號3樓",
        "主製造廠": "",
        "製造廠名稱": "FIT0239000  ALFASIGMA S.P.A."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6836800230",
            "成分名稱": "L-CARNITINE INNER SALT",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "02023934仿單-108-01-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023934&Seq=006&Type=9"
        },
        {
            "title": "02023934外盒-108-01-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023934&Seq=005&Type=8"
        }
    ]
}